Blog

■ Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management

Erika B. Rosenzweig, Steven H. Abman, Ian Adatia et al

Eur Respir J. 2019, vol 53(1): 1801916

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351335/

 

■ Risk stratification and medical therapy of pulmonar hypertension

Nazzareno Galiè, Richard N. Channick, Robert P. Frantz et al

Eur Respir J. 2019 Jan; 53(1): 1801889

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351343/

 

■ Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Marc Humbert, Harrison W. Farber, Hossein-Ardeschir Ghofrani et al

Eur Respir J. 2019 Jun; 53(6): 1802004

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551213/

 

■ Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Marc Humbert, Christophe Guignabert, Sébastien Bonnet et al

Eur Respir J. 2019 Jan; 53(1): 1801887.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351340/

 

■ Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

David G. Kiely, David L. Levin, Paul M. Hassoun et al

Pulm Circ. 2019 Jul-Sep; 9(3): 2045894019841990

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732869/

 

■ Pulmonary hypertension in chronic lung disease and hypoxia

Steven D. Nathan, Joan A. Barbera, Sean P. Gaine et al

Eur Respir J. 2019, vol 53(1): 1801914.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351338/

 

■ Genetics and genomics of pulmonary arterial hypertension

Nicholas W. Morrell, Micheala A. Aldred, Wendy K. Chung et al

Eur Respir J. 2019 Jan; 53(1): 1801899

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351337/

 

■ Malnutrition in pulmonary arterial hypertension: a possible role for dietary intervention

Chermaine T. Kwant, Gerrina Ruiter, Anton Vonk Noordegraaf

Curr Opin Pulm Med. 2019 Sep; 25(5): 405–40

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693930/

 

■ Chronic thromboembolic pulmonary hypertension

Nick H. Kim, Marion Delcroix, Xavier Jais, et al

Eur Respir J. 2019, vol 53(1): 1801915

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351341/

 

■ Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension

Kirsty M. Mair, Katie Y. Harvey, Alasdair D. Henry et al

Eur Respir J. 2019 Jun; 53(6): 1801524

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581204/

 

■ Clinical trial design and new therapies for pulmonar arterial hypertension

Olivier Sitbon, Mardi Gomberg-Maitland, John Granton et al

Eur Respir J. 2019 Jan; 53(1): 1801908

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351342/

 

■ Identification patients with pulmonary arterial hypertension using administrative claims algorithms

S C Mathai, A R Hemnes, S Manaker et al

Annals of the American Thoracic Society 2019, vol 16 (7)

https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201810-672CME

 

■ Current knowledge and recente advances of right ventricular molecular biology and metabolismo from congenital heart disease to chronic pulmonar hypertension

S Guimaron, J Guihaire, M Amsallem et al

BioMed Research International 2018 , Article ID 1981568, 10 pages

https://www.hindawi.com/journals/bmri/2018/1981568/

 

■ Hipertensão Pulmonar: Organizações Médicas Online (Pulmonary Hypertension: Medical Organizations)

https://internetmedica.com.br/hipertensao-pulmonar-organizacoes-medicas-online-pulmonary-hypertension-medical-organizations/

 

■ Hipertensão Pulmonar: Casos Clínicos Online (Pulmonary Hypertension: Case Reports)

https://internetmedica.com.br/hipertensao-pulmonar-casos-clinicos-online-pulmonary-hypertension-case-reports/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: out 2019

 

■ Canadiam Medical Association Journal

Série Five Things to Know About

 

■ Eosinophilic esophagitis: Five things to Know About

Thurarshen Jeyalingam, Samir C. Grover

CMAJ. 2018 Apr 30; 190(17): E542

1 – Eosinophilic esophagitis is becoming more common

2 – Eosinophilic esophagitis should be suspected in patients presenting with dysphagia or food bolus obstruction

3 – Endoscopic findings alone are not sufficient to make a diagnosis of eosinophilic esophagitis

4 – Proton pump inhibitors should be prescribed for a histologic finding of esophageal eosinophilia

5 – Topical steroids and elimination diets are the mainstays of therapy

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929894/

 

■ Hepatopulmonary syndrome: Five Things to Know About

Samir Gupta, Michael J. Krowka

CMAJ. 2018 Feb 26; 190(8): E223.

1 – Hepatopulmonary syndrome is defined by lliver disease, intrapulmonary vascular dilatation and abnormal oxygenation

2 – Hepatopulmonary syndrome is not uncommon among patients with liver disease

3 – Hepatopulmonary syndrome should be considered in patients with liver disease and na unxplained oxygen saturation of less than 96%, or any of platypnea, orthodeoxia, clubbing or cyanosis

4 – Liver transplantation is the only known cure for the syndrome

5 – Hepatopulmonary syndrome and portopulmonary hypertension are not the same disease

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826708/

 

■ Fecal microbiota transplantation for recurrent Clostridium difficile infection: Five Things to Know About

Susy S. Hota, Susan M. Poutanen

CMAJ. 2018 Jun 18; 190(24): E746

1 – Fecal microbiota transplantation is an effective treatment for recurrent Clostridium difficile

2 – Most fecal microbiota transplantation

are performed by gastroenterologists and infectious disease specialists

3 – Donors should be rigously screened

4 – There are four ways to administer fecal microbiota transplantation

5 – The long-term health effects are unknow

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008194/

 

■ Inflammatory bowel disease in pregnancy: Five Things to Know About

Amelie I. Stritzke, Cynthia H. Seow

CMAJ. 2017 May 8; 189(18): E669

1 – In most women with inflammatory bowel disease (IBD), the condition is diagnosed during prime child-bearing years

2 – Active IBD (Crohn disease or ulcerative colitis) during conception and pregnancy increases the risk of adverse pregnancy outcomes

3 – Except for metrotrexate, IBD therapies should be continued throughout pregnancy and lactation to optimize and maintain disease control

4 – Vaginal delivery should be considered in women with IBD unless they have active perianal disease or have undergone an ieloanal anastomosis

5 – Transplacental transfer of biologic therapies, specifically anti-TNF-alpha therapy, menas that the live rotavirus vaccines scheduled at two and four months of age should be omitted

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422151/

 

■ Loperamide abuse: Five Things to Know About

Tony Antoniou, David N. Juurlink

CMAJ. 2017 Jun 12; 189(23): E803

1 – Loperamide is not just an innocuous antidiarrheal agent

2 – Abuse of loperamide is increasing

3 – Patientes may present with cardiac manifestations without overt opioid toxicity

4 – Diagnosis of loperamide abuse requires a high index of suspicion

5 – Treatment is mostly supportive

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468105/

 

■ Acute mesenteric ischemia: Five Things to Know About

N D Dattani, R Horvath

CMAJ. 2016 Aug 9, 188 (11): 820

1 – Acute mesenteric ischemia is caused by arterial insufficiency or venous obstruction

2 – The diagnosis is made most reliabley with angiography or surgery

3 – In the absence of peritonitis, minimally invasive treatment options can be considered

4 – Mortality rates are high, even with appropriate management

5 – Long-term antiplatelet or anticoagulation treatment may be indicated, depending on the cause of the ischemia

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978579/

 

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com